AGA Exosome Therapy: Hair Regeneration Potential with ASCE+ HRLV | TASAKI PHAMA

What is Exosome Therapy? Potential in AGA Treatment

Exosome therapy is a field of regenerative medicine that has been attracting attention in recent years. Exosomes are tiny vesicles with a diameter of about 50-150nm secreted from cells, and contain bioactive substances such as proteins, mRNA, and miRNA. These substances are responsible for intercellular communication and are known to affect various physiological functions such as tissue repair and immune regulation.

AGA (androgenetic alopecia) is a progressive hair loss condition in which the male hormone dihydrotestosterone (DHT) acts on hair follicles, shortening the hair cycle and causing hair to become thinner and shorter. Conventional AGA treatments have used drugs that inhibit DHT production (finasteride, dutasteride, etc.) and drugs that promote blood flow to hair follicles (minoxidil, etc.). However, these drugs have issues such as the risk of side effects and individual differences in efficacy.

Exosome therapy is expected to be a new treatment option for AGA that overcomes these challenges. Bioactive substances such as growth factors and cytokines contained in exosomes may activate hair follicle cells and promote angiogenesis, thereby promoting hair growth. In particular, the effect of activating the Wnt signaling pathway, which is said to play an important role in hair regeneration, is attracting attention.

Main Growth Factors and Cytokines Contained in Exosomes

• VEGF (Vascular Endothelial Growth Factor): Promotes angiogenesis and improves nutrient supply to hair follicles
• bFGF (Basic Fibroblast Growth Factor): Promotes proliferation of hair matrix cells
• KGF (Keratinocyte Growth Factor): Promotes hair follicle cell growth
• IGF-1 (Insulin-like Growth Factor-1): Promotes hair follicle cell survival

Exosome therapy is expected to be applied not only to AGA but also to FAGA (female pattern hair loss) and hair loss due to anticancer drug treatment.

ASCE+ HRLV Scalp Exosomes: The Effect of 10 Billion Particles

ASCE+ HRLV is a scalp exosome product developed by Exosome Japan Co., Ltd. The main component is human adipose-derived stem cell exosomes, and one vial contains 10 billion exosome particles. It also contains active ingredients such as 5 types of growth factors, 6 types of peptides, 5 types of minerals, 19 types of amino acids, glutathione, and coenzyme Q10 that promote hair growth.

It is believed that by directly applying or injecting ASCE+ HRLV into the scalp, the bioactive substances contained in exosomes act on hair follicle cells and promote hair growth. In particular, the following effects are expected:

• Activation and proliferation promotion of hair follicle cells
• Normalization of the hair cycle
• Improvement of hair quality (thickness, firmness, and elasticity)
• Improvement of the scalp environment (inflammation suppression, moisturization)

ASCE+ HRLV can also be used in combination with AGA treatments (finasteride, minoxidil). It is believed that a synergistic effect can be expected by using them together. In addition, it may be a new treatment option for those who have not achieved results with conventional AGA treatments or who are concerned about side effects.

Main Ingredients Contained in ASCE+ HRLV

• Human Adipose-Derived Stem Cell Exosomes
• Growth Factors: VEGF, bFGF, KGF, IGF-1, PDGF
• Peptides: Copper Tripeptide-1, Acetyl Hexapeptide-8, etc.
• Minerals: Magnesium Chloride, Potassium Chloride, etc.
• Amino Acids: Alanine, Arginine, etc.

We do not provide import agency services for ASCE+ HRLV. Please contact a medical institution.

Clinical Application of Exosome Therapy: Combined Use with Hair Transplantation

Exosome therapy is also considered effective when used in combination with hair transplantation surgery. Hair transplantation surgery is a surgical treatment method in which hair follicles are collected from the back of the head and sides of the head, which are less susceptible to AGA, and transplanted to the hair loss area. Hair transplantation surgery can be expected to have a high hair growth effect, but it takes time for the transplanted hair follicles to take root, and there are individual differences in the engraftment rate.

By using exosome therapy in combination with hair transplantation surgery, it is expected to increase the engraftment rate of the transplanted hair follicles and promote early hair growth. Growth factors and cytokines contained in exosomes promote angiogenesis in the transplanted area and improve nutrient supply to the hair follicles, thereby helping the hair follicles to take root.

Specific methods include applying or injecting exosomes into the scalp before and after hair transplantation surgery, or soaking the hair follicles to be transplanted in an exosome solution. These methods promote the activation of the transplanted hair follicles and aim for a more natural and beautiful finish.

Potential of Exosome Therapy in Hair Transplantation Surgery

• Improved engraftment rate of transplanted hair follicles
• Promotion of early hair growth
• Suppression of inflammation
• Promotion of wound healing

Clinical research on the combined use of exosome therapy and hair transplantation surgery is still limited, but future research results are expected.

Risks and Safety of Exosome Therapy

Exosome therapy is a relatively new treatment method, and there is still not enough data on long-term safety. However, at present, there are almost no reports of serious side effects, and it is considered to be a relatively safe treatment method.

Possible side effects of exosome therapy include swelling, redness, pain, and itching at the injection site. These symptoms usually disappear naturally within a few days. In rare cases, an allergic reaction to exosome products may occur. If you have an allergic constitution, be sure to consult with your doctor in advance.

As a precaution regarding the safety of exosome therapy, quality control of exosome products is important. Exosome products are manufactured through processes such as cell culture and purification, but products that have undergone inappropriate manufacturing processes have risks such as contamination with bacteria or viruses, and contamination with impurities. Therefore, when receiving exosome therapy, be sure to use exosome products that have undergone thorough quality control at a reliable medical institution.

Exosome therapy also has ethical issues. In particular, there are cases where treatments using unapproved exosome products or treatments whose efficacy and safety have not been sufficiently verified are being performed. When receiving exosome therapy, be sure to receive a sufficient explanation from your doctor and make a careful decision after understanding the treatment content and risks. Public institutions such as the FDA (U.S. Food and Drug Administration) are also issuing warnings regarding the use of unapproved exosome products.

Summary

Exosome therapy in AGA treatment is attracting attention as a treatment method with new potential for hair regeneration. Scalp exosome products such as ASCE+ HRLV are expected to activate hair follicle cells and promote angiogenesis, thereby promoting hair growth. Combined use with hair transplantation surgery may also lead to further effects.

However, exosome therapy is still a new treatment method, and further research is needed on long-term safety and efficacy. When receiving exosome therapy, it is important to receive a sufficient explanation from your doctor and make a careful decision after understanding the treatment content and risks. It is also necessary to pay attention to quality control of exosome products and ethical issues.

Future research is expected to establish the efficacy and safety of exosome therapy and become a new standard for AGA treatment.